Democratic leaders at the Democratic National Convention this week stressed a commitment to universal healthcare. But just a few miles away, the head of a clinic serving low-income and uninsured patients is watching the election nervously.
The CMS is moving forward with a payment increase to skilled-nursing facilities, inpatient rehabilitation facilities and hospice care that also sets new quality measures.
A list of the 20 largest healthcare merger-and-acquisition deals through June 2016, ranked by announced purchase price based on Modern Healthcare reporting. Source: Modern Healthcare Mergers & Acquisitions premium database. Published July 25, 2016, p. 34.
The American Medical Association has partnered with Intermountain Healthcare and a health information technology firm in an effort to use digital health services to prevent Type 2 diabetes.
Molina Healthcare beat profit expectations in the second quarter following a brutal start to the year, but the Medicaid managed-care insurer still reported lower overall net income.
The head of the National Institute of Allergy and Infectious Diseases said Friday that preparations for the second phase of vaccine testing may be impossible without more money, which will be difficult to obtain with Congress on a weeks-long break.
LifePoint Health reported a net income drop in the second quarter of almost 60% to $20.1 million. The hospital chain's CEO said the lion's share of the earnings miss was caused by the abrupt departure of several physicians at an undisclosed hospital.
The Federal Trade Commission ruled Friday that a clinical laboratory's lax data security practices violated federal law – a decision that some say could mean tougher enforcement for healthcare providers.
The CMS published the much-anticipated Overall Hospital Quality Star Ratings on Wednesday after industry stakeholders and Congress pressured the agency to continue to delay their release. See a complete, searchable list at the bottom of this story.
Lilly CEO John Lechleiter will retire in December after leading the drugmaker through a challenging period in which it lost U.S. patent protection for several top-selling products. David Ricks, president of its biomedicines business, will replace Lechleiter in January.
We asked readers to vote for up to 10 innovations. These are the 25 that garnered the most votes, including storefront healthcare, bionic limbs and primary-care access.